Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Theralase current status

<< Previous

Bullboard Posts

Next >>

Comment by fredgoodwinsonon Jun 16, 2021 6:07pm

354 Views

Post# 33399527

RE:Theralase current status

The last person to ask on such matters NorCal and defer both to those from a medical background who we are lucky to have as contributors here and to those who research as thoroughly as does Eoganacht.

Like you his suggestion that NIR PDT will likely be required in addition to the Rutherrin/ low dose x-ray combination was news to me though this possibility was left open by the wording of the Quarterly.

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (Nov. 22, 2024)